Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting125%
withdrawn125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

IV Fluids and Post-ERCP Pancreatitis

NCT05211206
completedphase_4

Contrast Nephropathy and Nitrates

NCT01999517
withdrawnnot_applicable

Early Goal Directed Therapy in Sepsis by Emergency Medical Services

NCT02266654
completednot_applicable

Intravenous Fluids Versus Naso/Orogastric-tube Feeding in Hospitalized Infants With Bronchiolitis

NCT01189149

Clinical Trials (4)

Showing 4 of 4 trials
NCT05211206

IV Fluids and Post-ERCP Pancreatitis

Recruiting
NCT01999517Phase 4

Contrast Nephropathy and Nitrates

Completed
NCT02266654Not Applicable

Early Goal Directed Therapy in Sepsis by Emergency Medical Services

Withdrawn
NCT01189149Not Applicable

Intravenous Fluids Versus Naso/Orogastric-tube Feeding in Hospitalized Infants With Bronchiolitis

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4